| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.97B | 2.77B | 2.71B | 2.48B | 2.60B |
| Gross Profit | 337.89M | 458.26M | 398.72M | 434.09M | 411.79M |
| EBITDA | 90.86M | -7.16M | 30.09M | 125.81M | 143.14M |
| Net Income | -41.91M | -127.97M | -55.32M | -4.88M | -9.30M |
Balance Sheet | |||||
| Total Assets | 1.91B | 2.03B | 1.95B | 1.94B | 2.05B |
| Cash, Cash Equivalents and Short-Term Investments | 142.72M | 134.05M | 135.96M | 122.78M | 184.56M |
| Total Debt | 274.65M | 259.73M | 300.36M | 306.61M | 401.05M |
| Total Liabilities | 1.14B | 1.28B | 1.10B | 1.09B | 1.15B |
| Stockholders Equity | 769.65M | 749.82M | 853.93M | 847.95M | 896.94M |
Cash Flow | |||||
| Free Cash Flow | 35.84M | -17.77M | 21.93M | 58.92M | -120.58M |
| Operating Cash Flow | 168.20M | 99.61M | 70.74M | 114.02M | -66.12M |
| Investing Cash Flow | -128.78M | -108.60M | -31.52M | -47.32M | -43.71M |
| Financing Cash Flow | -38.47M | 12.66M | -32.68M | -103.66M | -79.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$165.02B | 19.54 | 24.34% | 4.35% | 16.74% | 24.19% | |
65 Neutral | HK$45.64B | 5.90 | 12.26% | 1.39% | 11.26% | 15.82% | |
64 Neutral | HK$25.97B | 9.04 | 9.88% | 2.03% | -3.02% | 11.38% | |
62 Neutral | HK$12.80B | 13.39 | 4.89% | 1.02% | 7.11% | 65.26% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$14.44B | 24.10 | 8.45% | 1.37% | 24.97% | 0.39% | |
56 Neutral | HK$10.34B | -75.86 | -3.48% | ― | 6.97% | 76.15% |